Home › Funds › KEYSTONE INVESTORS PTE LTD › BNTX

KEYSTONE INVESTORS PTE LTD position in BNTX

BIONTECH SE · Health Care

KEYSTONE INVESTORS PTE LTD reported holding 88,400 shares of BNTX (BIONTECH SE) in its Q3 2026 13F filing — a position valued at US$8.7M, representing 0.35% of its reported portfolio and ranking #33 among its reported holdings. KEYSTONE INVESTORS PTE LTD has disclosed BNTX holdings in 3 of the last 9 reported quarters, going back to Q3 2024.

Latest position (Q3 2026)88.40K sh
Reported value held$8.69M
Portfolio Weight0.35%
First reportedQ3 2024
Last changeReduce
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How KEYSTONE INVESTORS PTE LTD's BNTX position evolved

KEYSTONE INVESTORS PTE LTD first disclosed a stake in BNTX in Q3 2024 at 10,678 shares (US$1.3M). The position peaked in Q2 2026 at 153,466 shares, worth US$14.3M. Across 3 filings, KEYSTONE INVESTORS PTE LTD increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 88,400 shares valued at US$8.7M — a reduction of -65,066 shares quarter over quarter.. Notable position changes include a 42% trim in Q3 2026 (shares fell 13% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2024 10.68K $1.27M New
Q2 2026 153.47K $14.28M New
Q3 2026 88.40K $8.69M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BNTX and 13F data

BNTX (BIONTECH SE) is a Health Care company. 28 other funds we track also report a position in BNTX — the largest reported positions include Davern Capital Partners, LP (US$67.1M), GSK plc (US$65.7M), Logos Global Management LP (US$63.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BNTX

All BNTX fund holders →

FAQ

How long has KEYSTONE INVESTORS PTE LTD held BNTX?

KEYSTONE INVESTORS PTE LTD has disclosed BNTX holdings in 3 of the last 9 reported quarters, going back to Q3 2024.

What is KEYSTONE INVESTORS PTE LTD's current position in BNTX?

As of Q3 2026, KEYSTONE INVESTORS PTE LTD holds 88.40K shares of BNTX (BIONTECH SE), valued at $8.69M, representing 0.35% of its reported portfolio and ranking #33.

Has KEYSTONE INVESTORS PTE LTD been buying or selling BNTX?

In the latest 13F filing (Q3 2026), KEYSTONE INVESTORS PTE LTD reduced its position in BNTX. The position peaked in Q2 2026 at 153.47K shares.

Which other funds hold BNTX?

Other major institutional holders of BNTX include Davern Capital Partners, LP, GSK plc, Logos Global Management LP, among 28 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.